Pratia Prague s.r.o.
- Address
- lock Available on a paid plan
CCR Prague s.r.o. - Dermatology and Rheumatology Research Center
CCR Prague s.r.o. is a specialized clinical research facility with extensive expertise in inflammatory and autoimmune conditions, particularly focusing on dermatological and rheumatological disorders. The center has established itself as a leading site for evaluating novel therapeutics across multiple therapeutic areas, with a strong emphasis on immune-mediated diseases.
- Psoriatic diseases including plaque psoriasis and psoriatic arthritis, evaluating both established biologics and innovative oral therapies
- Musculoskeletal disorders including axial spondyloarthritis and knee osteoarthritis, with focus on pain management and disease modification
- Migraine prevention studies, including chronic and episodic migraine as well as menstrual migraine
- Atopic dermatitis research with long-term safety and efficacy evaluations
The center demonstrates particular strength in conducting comprehensive Phase 2 and Phase 3 clinical trials, including dose-ranging studies and long-term extension trials. Their research portfolio encompasses both traditional biologic therapies and emerging treatment modalities, including novel immunotherapies, targeted small molecules, and topical formulations. CCR Prague's expertise in managing complex inflammatory conditions positions them as a valuable partner for pharmaceutical companies developing next-generation treatments for immune-mediated and pain-related disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 6 therapeutic areas and 15 of 26 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1Novo Nordisk A/S2active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.4trials
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Pratia Prague s.r.o.
lock Showing 1 of 29 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-blind, Placebo- controlled, Parallel-group, Dose-ranging Study to Evaluate the Efficacy and Safety of DC-806 in Participants with Moderate to Severe Plaque Psoriasis | Dice Therapeutics Inc. | Phase II | Not Recruiting | Aug 2023 | Mar 2024 |
IMP list
lock Showing 1 of 26 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Atogepant | 3 | Unknown | 2021-08-16 | 2025-03-05 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.